Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Clinical Trials as Topic"" wg kryterium: Temat


Tytuł :
Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence.
Autorzy :
Helanterä I; Department of Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Snyder J; Hennepin Healthcare Research Institute, Minneapolis, MN, United States.
Åsberg A; Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.; Department of Pharmacy, University of Oslo, Oslo, Norway.
Cruzado JM; Department of Nephrology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Clinical Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Bell S; Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.; The Scottish Renal Registry, Scottish Health Audits, Public Health and Intelligence, Information Services, Glasgow, United Kingdom.
Legendre C; Hôpital Necker, Assistance Publique Hôpitaux de Paris (AP-HP) and Université Paris Descartes, Paris, France.
Tedesco-Silva H Jr; Nephrology Division, Hospital do Rim, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Barcelos GT; Novartis Pharma AG, Basel, Switzerland.
Geissbühler Y; Novartis Pharma AG, Basel, Switzerland.
Prieto L; Novartis Pharma AG, Basel, Switzerland.
Christian JB; IQVIA Real-World Solutions, Durham, NC, United States.
Scalfaro E; IQVIA Real-World Solutions, Basel, Switzerland.
Dreyer NA; IQVIA Real-World Solutions, Cambridge, MA, United States.
Pokaż więcej
Źródło :
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 May 03; Vol. 35, pp. 10329. Date of Electronic Publication: 2022 May 03 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Kidney Transplantation*/adverse effects
Pragmatic Clinical Trials as Topic*/standards
Risk Assessment*
Clinical Trials as Topic/standards ; Graft Survival ; Humans ; Research Design/standards
Czasopismo naukowe
Tytuł :
Expanding Evidence for Clinical Care of Older Adults: Beyond Clinical Trial Traditions and Finding New Approaches.
Autorzy :
Steinman MA; Division of Geriatrics, Department of Medicine, University of California, San Francisco.; San Francisco VA Health Care System, San Francisco.
Boyd CM; Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Schmader KE; Division of Geriatrics, Department of Medicine, Duke University, Durham, North Carolina.; Durham VA Health Care System, Durham, North Carolina.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 Aug 10; Vol. 326 (6), pp. 475-476.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Clinical Trials as Topic*/legislation & jurisprudence
Clinical Trials as Topic*/standards
Patient Selection*
Aged ; Health Services for the Aged ; Health Status Disparities ; Humans ; National Institutes of Health (U.S.) ; Pragmatic Clinical Trials as Topic ; United States
Czasopismo naukowe
Tytuł :
COVID-19 clinical trials: learning from exceptions in the research chaos.
Autorzy :
Tikkinen KAO; Departments of Urology and Public Health, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Surgery, South Karelian Central Hospital, Lappeenranta, Finland.
Malekzadeh R; Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Schlegel M; Department of Anesthesiology and Intensive Care, Technical University of Munich School of Medicine, Munich, Germany.
Rutanen J; Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Glasziou P; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2020 Nov; Vol. 26 (11), pp. 1671-1672.
Typ publikacji :
Historical Article; Letter
MeSH Terms :
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/organization & administration
Clinical Trials as Topic*/standards
Pandemics*/history
Biomedical Research/*organization & administration
COVID-19/*therapy
Biomedical Research/history ; Biomedical Research/standards ; COVID-19/diagnosis ; COVID-19/epidemiology ; Canada/epidemiology ; Community Networks/organization & administration ; Community Networks/standards ; Drug Evaluation, Preclinical/methods ; Drug Evaluation, Preclinical/standards ; Europe/epidemiology ; History, 21st Century ; Humans ; International Cooperation ; Learning ; Neural Networks, Computer ; Organizational Innovation ; Patient Selection ; Pragmatic Clinical Trials as Topic/methods ; Pragmatic Clinical Trials as Topic/standards ; Research Design ; Scandinavian and Nordic Countries/epidemiology ; United Kingdom/epidemiology ; World Health Organization/organization & administration
Opinia redakcyjna
Tytuł :
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
Autorzy :
Salmanton-García J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Stewart FA; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Heringer S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Koniordou M; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Álvarez-Barco E; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland.
Argyropoulos CD; European University of Cyprus, Nicosia, Cyprus.
Themistocleous SC; European University of Cyprus, Nicosia, Cyprus.
Valle-Simón P; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Spivak O; Ministry of Health of Israel, Jerusalem, Israel.
Součková L; Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic.
Merakou C; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Amélia Mendonça M; Centro Hospitalar Universitário do Porto, Porto, Portugal.
Joanna Davis R; University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy.
Maria Azzini A; University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy.
Askling HH; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Vene S; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Van Damme P; Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium.
Steinbach A; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Shiamakkides G; European University of Cyprus, Nicosia, Cyprus.
Seidel D; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Olesen OF; European Vaccine Initiative (EVI), Heidelberg, Germany.
Noula E; European University of Cyprus, Nicosia, Cyprus.
Macken A; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland.
Luís C; European Vaccine Initiative (EVI), Heidelberg, Germany.
Leckler J; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Launay O; Institut National de la Santé et de la Recherche Médicale-ANRS Maladies Infectieuses Émergentes, Paris, France; Université Paris Cité, Assistance Publique Hopitaux de Paris, Paris, France.
Isitt C; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Hellemans M; Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium.
Frías-Iniesta J; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Di Marzo R; European Vaccine Initiative (EVI), Heidelberg, Germany.
Carcas AJ; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Boustras G; European University of Cyprus, Nicosia, Cyprus.
Borobia AM; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain.
Barta I; National Koranyi Institute for Pulmonology, Budapest, Hungary.
Albus K; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Akova M; Haceteppe University, Ankara, Turkey.
Ochando J; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Cohen-Kandli M; Ministry of Health of Israel, Jerusalem, Israel.
Jane Cox R; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Husa P; Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic.
Jancoriene L; Institute of Clinical Medicine, Medical Faculty, Vilnius University|Institute of Clinical Medicine, Medical Faculty, Vilnius University; Vilnius University Hospital Santaros klinikos, Vilnius University, Medical Faculty, Vilnius, Lithuania.
Mallon P; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland.
Marques L; Centro Hospitalar Universitário do Porto, Porto, Portugal.
Mellinghoff SC; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany.
Nauclér P; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Tacconelli E; University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy.
Tóth K; National Koranyi Institute for Pulmonology, Budapest, Hungary.
Zaoutis TE; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
Zeitlinger M; Medical University of Vienna, Vienna, Austria.
Cornely OA; University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany.
Pana ZD; European University of Cyprus, Nicosia, Cyprus.
Pokaż więcej
Corporate Authors :
VACCELERATE consortium
Źródło :
Vaccine [Vaccine] 2022 Jul 29; Vol. 40 (31), pp. 4090-4097. Date of Electronic Publication: 2022 Jun 02.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
Clinical Trials as Topic*
Patient Participation*
Adult ; Child ; Europe/epidemiology ; Humans ; Registries ; Volunteers
Czasopismo naukowe
Tytuł :
New FDA guidance recommends increasing the number of older adults in cancer clinical trials: The guidance is intended to assist in evaluating cancer therapies in adults aged 65 years and older: The guidance is intended to assist in evaluating cancer therapies in adults aged 65 years and older.
Autorzy :
O'Rourke K
Pokaż więcej
Źródło :
Cancer [Cancer] 2022 Jul 01; Vol. 128 (13), pp. 2397-2398.
Typ publikacji :
Wiadomości
MeSH Terms :
Clinical Trials as Topic*
Neoplasms*/therapy
Aged ; Humans ; United States ; United States Food and Drug Administration
Periodyk
Tytuł :
Ensuring diversity in clinical trials: The role of clinical pharmacology.
Autorzy :
Masters JC; Pfizer Inc, 10777 Science Center Dr, San Diego, CA 92121, USA. Electronic address: .
Cook JA; Pfizer Inc, 445 Eastern Point Rd, Groton, CT 06340, USA.
Anderson G; Pfizer Inc, 445 Eastern Point Rd, Groton, CT 06340, USA.
Nucci G; Pfizer Inc, 1 Portland Street, Cambridge, MA 02139, USA.
Colzi A; Pizer Clinical Research Unit, Route de Lennik, 808, Anderlecht, Belgium.
Hellio MP; Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA.
Corrigan B; Pfizer Inc, 445 Eastern Point Rd, Groton, CT 06340, USA.
Pokaż więcej
Źródło :
Contemporary clinical trials [Contemp Clin Trials] 2022 Jul; Vol. 118, pp. 106807. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Cultural Diversity*
Pharmacology, Clinical*
Aged ; Child ; Ethnicity ; Humans ; Racial Groups
Czasopismo naukowe
Tytuł :
Analysis of female enrollment in clinical trials for alcohol and substance use disorders: Is it time for sex-informed pharmacotherapy?
Autorzy :
Montemitro C; Department of Neuroscience, Imaging, and Clinical Science, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy; Neuroimaging Research Branch, Intramural Research Program, National Institute of Drug Abuse, NIH, Baltimore, MD, USA.
Cavallotto C; Department of Neuroscience, Imaging, and Clinical Science, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Giovannetti G; Department of Neuroscience, Imaging, and Clinical Science, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Martino F; Department of Neuroscience, Imaging, and Clinical Science, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Pasino A; Department of Neuroscience, Imaging, and Clinical Science, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Vicinelli MC; Department of Neuroscience, Imaging, and Clinical Science, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Fraticelli S; Department of Mental Health, ASL Roma 1, Early Intervention and Prevention in Mental Health Unit, Rome, Italy.
Di Giannantonio M; Department of Neuroscience, Imaging, and Clinical Science, University 'G. d'Annunzio' of Chieti-Pescara, Chieti, Italy.
Spagnolo PA; Mary Horrigan Connors Center for Women's Health and Gender Biology, Department of Psychiatry, Brigham and Women's Hospital, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Contemporary clinical trials [Contemp Clin Trials] 2022 Jul; Vol. 118, pp. 106784. Date of Electronic Publication: 2022 May 23.
Typ publikacji :
Journal Article
MeSH Terms :
Alcoholism*/drug therapy
Clinical Trials as Topic*
Patient Participation*
Drugs, Investigational/therapeutic use ; Female ; Humans
Czasopismo naukowe
Tytuł :
Beyond privacy: A deeper understanding of the internet is required to protect digitized trial participants.
Autorzy :
Perakslis ED; Duke Clinical Research Institute, Department of Population Health Sciences, Duke University School of Medicine, 1 Oakcrest Road, Hingham, MA 02043, USA. Electronic address: .
Pokaż więcej
Źródło :
Contemporary clinical trials [Contemp Clin Trials] 2022 Jul; Vol. 118, pp. 106786. Date of Electronic Publication: 2022 May 15.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Privacy*
Computer Security ; Humans ; Internet
Czasopismo naukowe
Tytuł :
Paediatric surgical trials, their fragility index, and why to avoid using it to evaluate results.
Autorzy :
Schröder A; Klinik für Kinder- und Jugendmedizin, Klinikum Dortmund, Dortmund, Germany.
Muensterer OJ; Kinderchirurgische Klinik und Poliklinik im Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität München, München, Germany.; Klinik und Poliklinik für Kinderchirurgie, Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, Mainz, Germany.
Oetzmann von Sochaczewski C; Klinik und Poliklinik für Kinderchirurgie, Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, Mainz, Germany. .; Sektion Kinderchirurgie der Klinik und Poliklinik für Allgemein, Viszeral, Thorax- und Gefäßchirurgie, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. .
Pokaż więcej
Źródło :
Pediatric surgery international [Pediatr Surg Int] 2022 Jul; Vol. 38 (7), pp. 1057-1066. Date of Electronic Publication: 2022 May 07.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*/standards
Pediatrics*
Specialties, Surgical*
Child ; Humans
Czasopismo naukowe
Tytuł :
Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer.
Autorzy :
Weinstock C; Department of Oncology, United States Food and Drug Administration, Silver Spring, MD, USA. Electronic address: .
Agrawal S; Department of Oncology, United States Food and Drug Administration, Silver Spring, MD, USA.
Chang E; Department of Oncology, United States Food and Drug Administration, Silver Spring, MD, USA.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Jul; Vol. 82 (1), pp. 47-48. Date of Electronic Publication: 2022 Mar 15.
Typ publikacji :
Editorial
MeSH Terms :
Clinical Trials as Topic*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Humans ; Neoplasm Invasiveness ; Research Design
Opinia redakcyjna
Tytuł :
Ethical concern regarding the UK PANORAMIC COVID-19 trial.
Autorzy :
Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
Holm S; Centre for Social Ethics and Policy, Department of Law, School of Social Sciences, University of Manchester, Manchester, UK.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jul; Vol. 88 (7), pp. 3537-3538. Date of Electronic Publication: 2022 Feb 21.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/therapy
Clinical Trials as Topic*/ethics
Humans ; United Kingdom/epidemiology
Opinia redakcyjna
Tytuł :
Considerations regarding choice of primary outcome in clinical trials in deprescribing.
Autorzy :
Lundby C; Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark.; Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.; ODIN, Odense Deprescribing INitiative, Odense University Hospital and University of Southern Denmark, Odense, Denmark.
Pottegård A; Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark.; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.; ODIN, Odense Deprescribing INitiative, Odense University Hospital and University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jul; Vol. 88 (7), pp. 3032-3034. Date of Electronic Publication: 2021 Aug 07.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Deprescriptions*
Humans
Czasopismo naukowe
Tytuł :
The Imperative for Diversity and Inclusion in Clinical Trials and Health Research Participation.
Autorzy :
Bibbins-Domingo K; Department of Epidemiology and Biostatistics, University of California, San Francisco.
Helman A; National Academies of Sciences, Engineering, and Medicine, Washington, DC.
Dzau VJ; National Academy of Medicine, Washington, DC.
Pokaż więcej
Źródło :
JAMA [JAMA] 2022 Jun 21; Vol. 327 (23), pp. 2283-2284.
Typ publikacji :
Journal Article
MeSH Terms :
Biomedical Research*/standards
Clinical Trials as Topic*/standards
Cultural Diversity*
Patient Selection*
Prejudice*
Social Inclusion*
Czasopismo naukowe
Tytuł :
Approach for reporting master protocol study designs on ClinicalTrials.gov: qualitative analysis.
Autorzy :
Williams RJ; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Dobbins HD; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Tse T; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA .
Chon SD; Essex Management, Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Loose D; Essex Management, Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Sarosy GA; Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Prindiville SA; Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Rockhold FW; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Zarin DA; Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Cambridge, MA, USA.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2022 Jun 10; Vol. 377, pp. e067745. Date of Electronic Publication: 2022 Jun 10.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Research Design*
Databases, Factual ; Humans ; Qualitative Research ; Registries
Czasopismo naukowe
Tytuł :
Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru.
Autorzy :
De-Los-Rios-Pinto A; Escuela Profesional de Medicina Humana, Universidad Nacional San Antonio Abad del Cusco, Cusco, Peru.
Fernandez-Guzman D; Escuela Profesional de Medicina Humana, Universidad Nacional San Antonio Abad del Cusco, Cusco, Peru; Grupo Peruano de Investigación Epidemiológica, Unidad para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Perú.
Soriano-Moreno DR; Unidad de Investigación Clínica y Epidemiológica, Escuela de Medicina, Universidad Peruana Unión, Lima, Peru.
Sangster-Carrasco L; Universidad Peruana de Ciencias Aplicadas, Facultad de Medicina, Lima, Peru.
Morocho-Alburqueque N; Sociedad Científica de Estudiantes de Medicina de la Universidad Nacional de Piura, Piura, Perú.
Pinedo-Soria A; Facultad de Medicina Humana, Universidad Nacional de San Martín, Tarapoto, Peru. Electronic address: .
Murrieta-Ruiz V; Universidad Nacional de la Amazonía Peruana, Facultad de Medicina Humana Rafael Donayre Rojas, Iquitos, Loreto, Perú.
Diaz-Corrales A; Universidad de San Martín de Porres, Facultad de Medicina Humana, Chiclayo, Lambayeque, Peru.
Alave J; Universidad Peruana Union, Escuela de Medicina Humana, Lima, Peru; Deparment of Medicine, Clinica Good Hope, Lima, Peru. Electronic address: .
Nieto-Gutierrez W; Unidad de Investigación para la Generación de Síntesis de Evidencia en Salud, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru. Electronic address: wendy_.
Gonzales-Zamora J; Division of Infectious Diseases, Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA; Peruvian American Medical Society, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2022 Jun 09; Vol. 40 (26), pp. 3566-3572. Date of Electronic Publication: 2022 Apr 07.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*
Clinical Trials as Topic*
Intention*
Patient Participation*/psychology
COVID-19/epidemiology ; COVID-19/prevention & control ; Cross-Sectional Studies ; Female ; Humans ; Male ; Peru/epidemiology
Czasopismo naukowe
Tytuł :
End-point definition and trial design to advance tuberculosis vaccine development.
Autorzy :
Garcia-Basteiro AL; Centro de Investigação em Sade de Manhiça (CISM), Maputo, Mozambique .; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain.
White RG; London School of Hygiene and Tropical Medicine, London, UK.
Tait D; International AIDS Vaccine Initiative (IAVI) NPC, Cape Town, South Africa.
Schmidt AC; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.
Rangaka MX; Institute for Global Health and MRC Clinical Trials Unit at University College London, London, UK.; CIDRI-AFRICA, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Quaife M; London School of Hygiene and Tropical Medicine, London, UK.
Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
Mogg R; Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand.
Harris RC; London School of Hygiene and Tropical Medicine, London, UK.; Sanofi Pasteur, Singapore.
Hanekom WA; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Division of Infection and Immunity, University College London, London, UK.
Frick M; Treatment Action Group, New York, NY, USA.
Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Evans T; Vaccitech, Oxford, UK.
Dagnew AF; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.
Churchyard G; The Aurum Institute, Parktown, South Africa.; Vanderbilt University, Nashville, TN, USA.; University of the Witwatersrand, Johannesburg, South Africa.
Cobelens F; Dept of Global Health and Amsterdam Institute for Global health and development, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Behr MA; Dept of Medicine, McGill University; McGill International TB Centre, Montreal, QC, Canada.
Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło :
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2022 Jun 07; Vol. 31 (164). Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).
Typ publikacji :
Journal Article; Review
MeSH Terms :
Clinical Trials as Topic*/methods
Tuberculosis Vaccines*
Vaccine Development*
Adolescent ; Adult ; COVID-19/prevention & control ; Humans ; Mycobacterium tuberculosis ; Research Design ; Tuberculosis/prevention & control
Czasopismo naukowe
Tytuł :
Transplant Trial Watch.
Autorzy :
Knight SR; Oxford Transplant Centre, Churchill Hospital, Oxford, United Kingdom.; Centre for Evidence in Transplantation, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło :
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Jun 01; Vol. 35, pp. 10580. Date of Electronic Publication: 2022 Jun 01 (Print Publication: 2022).
Typ publikacji :
Editorial; Comment
MeSH Terms :
Clinical Trials as Topic*
Transplants*
Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies